🕵️ Hepion Pharmaceuticals, Inc. ($HEPA)
SEC insider & ownership activity, last 12 months · CIK 1583771 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. No red-flag 8-Ks in the window.
Insider flow
5 buyers, value withheld pending verification (11 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Vincent S. Lopriore | 4 | value withheld pending verification | 0 | – | Aug 3, 2026 |
| Michael J. Purcell | 2 | value withheld pending verification | 0 | – | Aug 3, 2026 |
| Gary S. Stetz | 2 | value withheld pending verification | 0 | – | Aug 3, 2026 |
| Appajosyula Sireesh | 2 | value withheld pending verification | 0 | – | Aug 3, 2026 |
| Gary S. Stetz II | 1 | $25K | 0 | – | Aug 3, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Vincent LoPriore | 26.2% | 13D | Aug 3, 2026 | filing ↗ | |
| Gravitas Capital LP | 21.4% | 13D | Aug 3, 2026 | filing ↗ | |
| Red Global 3, LLC | 11.1% | 13D | Jul 31, 2026 | filing ↗ | |
| Darin Feinstein | 11.1% | 13D | Jul 31, 2026 | filing ↗ | |
| Black Global 5 LLC | 11.1% | 13D | Jul 31, 2026 | filing ↗ | |
| KI Holdings Ltd. | 10.2% | 13D | Aug 3, 2026 | filing ↗ | |
| Bigger Capital Fund L P | 10.0% | 13G | Jan 24, 2025 | filing ↗ | |
| Bigger Capital Fund GP, LLC | 10.0% | 13G | Jan 24, 2025 | filing ↗ | |
| Bigger Michael | 10.0% | 13G | Jan 24, 2025 | filing ↗ | |
| Kenneth Rickel | 5.7% | 13G | Sep 15, 2026 | filing ↗ | |
| Invictus Capital Advisors Pension PLAN | 5.7% | 13D | Aug 3, 2026 | filing ↗ | |
| Sireesh Appajosyula | 5.7% | 13D | Aug 3, 2026 | filing ↗ | |
| Gary Stetz | 5.7% | 13D | Aug 3, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Sep 3, 2026 | filing ↗ |
| New financial obligation (2.03) | Sep 3, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 3, 2026 | filing ↗ |
| Material agreement (1.01) | Aug 25, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 25, 2026 | filing ↗ |
| Officer/director changes (5.02) | Aug 19, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 31, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 31, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 1, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 17, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 21, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 21, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 16, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 25, 2026 | filing ↗ |
| Other events (8.01) | Feb 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 3, 2026 | filing ↗ |